Retrospective evaluation of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in South India

Pai Sunil Bellare, Kamath Ashwin, Saxena Prakash Pu, Sayeli Vinaykumar, Rakesh Kb

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: To evaluate the adverse drug reactions (ADRs) due to cancer chemotherapy in a tertiary care hospital in South India. Materials and Methods: This was a retrospective descriptive study. The data was obtained from patients who developed, at least, one ADR due to cancer chemotherapy during the period June 2014 to May 2015. The causality of the ADRs were evaluated by WHO-UMC causality assessment system and Naranjo's ADR probability scale, the severity of ADRs were assessed by Hartwig and Siegel ADR severity assessment scale, and preventability of ADRs were determined by the Schumock and Thornton ADR preventability assessment scale. Results: One hundred fourteen ADRs due to cancer chemotherapy were reported in 73 patients. Hyponatremia (20.2%), neutropenia (11.4%), infections of the lung (11.4%), leucopenia (9.6%) were the commonly suspected ADRs. Cisplatin (62.3%), carboplatin (18.4%), cetuximab (3.5%), gefitinib (2.6%) were the commonly suspected medications. As per the WHO-UMC causality assessment system 66(57.8%) ADRs were possible and 48(42.1%) were probable. Naranjo's ADR probability scale showed that 74(64.9%) ADRs were possible and 40 (35.1%) were probable. There was a very good agreement between the two scales (kappa=0.853). All ADRs were classified as level 4 severity barring one. None of the ADRs reported were preventable. Conclusion: Since 80% of the ADRs were suspected to be due to platinum containing anticancer drugs this provides a focus for further research on devising methods for prevention or early detection of ADRs. Prompt detection of ADRs is important to decrease morbidity and mortality.

Original languageEnglish
Pages (from-to)251-254
Number of pages4
JournalJournal of Young Pharmacists
Volume8
Issue number3
DOIs
Publication statusPublished - 01-07-2016
Externally publishedYes

Fingerprint

Tertiary Healthcare
Drug-Related Side Effects and Adverse Reactions
Tertiary Care Centers
India
Drug Therapy
Neoplasms
Causality
Hyponatremia
Carboplatin
Leukopenia
Neutropenia
Platinum

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Bellare, Pai Sunil ; Ashwin, Kamath ; Pu, Saxena Prakash ; Vinaykumar, Sayeli ; Kb, Rakesh. / Retrospective evaluation of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in South India. In: Journal of Young Pharmacists. 2016 ; Vol. 8, No. 3. pp. 251-254.
@article{38aaa55568424ef4b2ea752243dec340,
title = "Retrospective evaluation of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in South India",
abstract = "Introduction: To evaluate the adverse drug reactions (ADRs) due to cancer chemotherapy in a tertiary care hospital in South India. Materials and Methods: This was a retrospective descriptive study. The data was obtained from patients who developed, at least, one ADR due to cancer chemotherapy during the period June 2014 to May 2015. The causality of the ADRs were evaluated by WHO-UMC causality assessment system and Naranjo's ADR probability scale, the severity of ADRs were assessed by Hartwig and Siegel ADR severity assessment scale, and preventability of ADRs were determined by the Schumock and Thornton ADR preventability assessment scale. Results: One hundred fourteen ADRs due to cancer chemotherapy were reported in 73 patients. Hyponatremia (20.2{\%}), neutropenia (11.4{\%}), infections of the lung (11.4{\%}), leucopenia (9.6{\%}) were the commonly suspected ADRs. Cisplatin (62.3{\%}), carboplatin (18.4{\%}), cetuximab (3.5{\%}), gefitinib (2.6{\%}) were the commonly suspected medications. As per the WHO-UMC causality assessment system 66(57.8{\%}) ADRs were possible and 48(42.1{\%}) were probable. Naranjo's ADR probability scale showed that 74(64.9{\%}) ADRs were possible and 40 (35.1{\%}) were probable. There was a very good agreement between the two scales (kappa=0.853). All ADRs were classified as level 4 severity barring one. None of the ADRs reported were preventable. Conclusion: Since 80{\%} of the ADRs were suspected to be due to platinum containing anticancer drugs this provides a focus for further research on devising methods for prevention or early detection of ADRs. Prompt detection of ADRs is important to decrease morbidity and mortality.",
author = "Bellare, {Pai Sunil} and Kamath Ashwin and Pu, {Saxena Prakash} and Sayeli Vinaykumar and Rakesh Kb",
year = "2016",
month = "7",
day = "1",
doi = "10.5530/jyp.2016.3.14",
language = "English",
volume = "8",
pages = "251--254",
journal = "Journal of Young Pharmacists",
issn = "0975-1483",
publisher = "E-Flow Medknow Publications",
number = "3",

}

Retrospective evaluation of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in South India. / Bellare, Pai Sunil; Ashwin, Kamath; Pu, Saxena Prakash; Vinaykumar, Sayeli; Kb, Rakesh.

In: Journal of Young Pharmacists, Vol. 8, No. 3, 01.07.2016, p. 251-254.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Retrospective evaluation of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in South India

AU - Bellare, Pai Sunil

AU - Ashwin, Kamath

AU - Pu, Saxena Prakash

AU - Vinaykumar, Sayeli

AU - Kb, Rakesh

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Introduction: To evaluate the adverse drug reactions (ADRs) due to cancer chemotherapy in a tertiary care hospital in South India. Materials and Methods: This was a retrospective descriptive study. The data was obtained from patients who developed, at least, one ADR due to cancer chemotherapy during the period June 2014 to May 2015. The causality of the ADRs were evaluated by WHO-UMC causality assessment system and Naranjo's ADR probability scale, the severity of ADRs were assessed by Hartwig and Siegel ADR severity assessment scale, and preventability of ADRs were determined by the Schumock and Thornton ADR preventability assessment scale. Results: One hundred fourteen ADRs due to cancer chemotherapy were reported in 73 patients. Hyponatremia (20.2%), neutropenia (11.4%), infections of the lung (11.4%), leucopenia (9.6%) were the commonly suspected ADRs. Cisplatin (62.3%), carboplatin (18.4%), cetuximab (3.5%), gefitinib (2.6%) were the commonly suspected medications. As per the WHO-UMC causality assessment system 66(57.8%) ADRs were possible and 48(42.1%) were probable. Naranjo's ADR probability scale showed that 74(64.9%) ADRs were possible and 40 (35.1%) were probable. There was a very good agreement between the two scales (kappa=0.853). All ADRs were classified as level 4 severity barring one. None of the ADRs reported were preventable. Conclusion: Since 80% of the ADRs were suspected to be due to platinum containing anticancer drugs this provides a focus for further research on devising methods for prevention or early detection of ADRs. Prompt detection of ADRs is important to decrease morbidity and mortality.

AB - Introduction: To evaluate the adverse drug reactions (ADRs) due to cancer chemotherapy in a tertiary care hospital in South India. Materials and Methods: This was a retrospective descriptive study. The data was obtained from patients who developed, at least, one ADR due to cancer chemotherapy during the period June 2014 to May 2015. The causality of the ADRs were evaluated by WHO-UMC causality assessment system and Naranjo's ADR probability scale, the severity of ADRs were assessed by Hartwig and Siegel ADR severity assessment scale, and preventability of ADRs were determined by the Schumock and Thornton ADR preventability assessment scale. Results: One hundred fourteen ADRs due to cancer chemotherapy were reported in 73 patients. Hyponatremia (20.2%), neutropenia (11.4%), infections of the lung (11.4%), leucopenia (9.6%) were the commonly suspected ADRs. Cisplatin (62.3%), carboplatin (18.4%), cetuximab (3.5%), gefitinib (2.6%) were the commonly suspected medications. As per the WHO-UMC causality assessment system 66(57.8%) ADRs were possible and 48(42.1%) were probable. Naranjo's ADR probability scale showed that 74(64.9%) ADRs were possible and 40 (35.1%) were probable. There was a very good agreement between the two scales (kappa=0.853). All ADRs were classified as level 4 severity barring one. None of the ADRs reported were preventable. Conclusion: Since 80% of the ADRs were suspected to be due to platinum containing anticancer drugs this provides a focus for further research on devising methods for prevention or early detection of ADRs. Prompt detection of ADRs is important to decrease morbidity and mortality.

UR - http://www.scopus.com/inward/record.url?scp=84973162063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973162063&partnerID=8YFLogxK

U2 - 10.5530/jyp.2016.3.14

DO - 10.5530/jyp.2016.3.14

M3 - Article

VL - 8

SP - 251

EP - 254

JO - Journal of Young Pharmacists

JF - Journal of Young Pharmacists

SN - 0975-1483

IS - 3

ER -